Established in 1997, CNR Research is the first independent CRO in Korea and has been involved in the inception and growth of the Korean clinical trial industry. We have established the concept of clinical trial outsourcing so that domestic pharmaceutical and biotech companies can focus on new drug development, and laid the foundation for the Korean CRO industry, and made numerous “firsts” in history.
CNR Research's unparalleled pioneering spirit and overwhelming experience have established the standard for clinical trials in Korea, and this unique first-mover advantage has been the core driving force behind its current position as the industry leader.

Since its establishment, CNR Research has successfully conducted more than 1,800 clinical trials and regulatory approval procedures, accumulating unparalleled expertise. This is by far the highest record among domestic CROs, and the vast amount of data and successful experience accumulated during this process are unique assets exclusive to C&R.
Through a proprietary quality management system that exceeds strict international standards (ICH-GCP) and the thorough execution of a group of skilled experts, CNR Research boasts the highest clinical trial success rate and data reliability in Korea.

C&R is a CRO that delivers an integrated one‑stop solution covering the full spectrum of new drug development—from initial clinical trial planning to final regulatory submission. Our top‑tier experts in Medical, Regulatory Affairs (RA), Data Management (DM), Biostatistics (STAT), and Pharmacovigilance (PV) work in seamless collaboration to provide customized solutions precisely tailored to each client’s needs.
More than a service provider, we act as a strategic partner dedicated to increasing the probability of success in new drug development. With C&R’s deep and proven expertise, we deliver client-specific clinical trial solutions.